Objective evaluation of EEG amplitude in chronic schizophrenic patients during a controlled trial of pimozide and trifluoperazine.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008722:Methods; D008875:Middle Aged; D010868:Pimozide / Q000627:therapeutic use*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors; D014268:Trifluoperazine / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D010868:Pimozide; D014268:Trifluoperazine